Dechert Re:Torts
- PFAS Out, Libel In: Testing the Boundaries of Defamation and Tortious Interference
- Plaintiff-Side Firms Bear the Burdensome Costs of Third-Party Litigation Lending
- A Class Act: Is England a New Battleground in High-Value Multi-Claimant Actions?
- The No-Harm Foul: U.S. Supreme Court to Decide Whether Class Actions Can Include Uninjured Plaintiffs
- Environmental Group Sues FDA over Inaction on PFAS in Food
- State Court Appeals to Watch in 2025
HOT TOPICS
A turf manufacturer who recently developed a PFAS-free turf sues for defamation after an environmental organization makes a blanket statement that PFAS can be found in most artificial turfs. Read more »
Third-party litigation funding presents significant financial risks for attorneys due to burdensome loan terms and the protracted nature of mass tort litigation. Read more »
Multi-claimant litigation in England has surged since 2022, with significant increases in CAT actions and GLOs, driven by high-value claims in areas such as data breaches and ESG, while courts continue to refine procedural mechanisms to manage these complex cases. Read more in our OnPoint.
CLASS NOTES
Supreme Court will clarify how standing factors into class certification. Read more.
ENVIRONMENTAL EDIT
Plaintiffs seek to force the FDA to set limits on PFAS levels in food. Read more.
JURISDICTIONAL JABBER
Appeals before the Washington Supreme Court in a PCB exposure case, the Supreme Court of California in litigation involving HIV medications, and the Supreme Court of Appeals of West Virginia in municipality cases against prescription opioid distributors are likely to have an impact beyond those actions. Read more.